ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
FDA approves IND for PSC’s stem cell therapy candidate for Covid-19 pharmaceutical-business-review
August 06, 2020Calidi Biotherapeutics said that the Investigational New Drug (IND) application submitted by its partner, Personalized Stem Cells, Inc. (PSC), has received FDA approval for the treatment of COVID-19 and pneumonia patients using stem cell therapy.
Pharma Sources Insight July 2025
